Cinnamomum zeylanicum Bark Oil
Also known as: Cinnamomum verum, True cinnamon, Ceylon cinnamon, Cinnamomum zeylanicum
Overview
Cinnamomum zeylanicum bark oil is an essential oil extracted from the bark of the true cinnamon tree, native to Sri Lanka and parts of India. It is primarily used for its antimicrobial, antioxidant, anti-inflammatory, and metabolic regulatory properties, often applied in traditional medicine and increasingly studied for pharmaceutical potential. Key characteristics include a high content of (E)-cinnamaldehyde (approximately 70-97%), along with minor constituents such as eugenol, linalool, and β-caryophyllene. Research maturity is moderate, with a growing number of in vitro, in vivo, and clinical studies; however, high-quality clinical evidence remains limited. Available evidence includes systematic reviews and meta-analyses, particularly regarding metabolic effects such as glycemic control in diabetes. It is classified as a phytochemical supplement.
Benefits
Cinnamomum zeylanicum bark oil exhibits several evidence-based benefits. Its primary effects include significant antimicrobial activity, demonstrating bactericidal effects against pathogens such as Escherichia coli, Clostridium difficile, and various fungi like Aspergillus and Candida species. Minimum inhibitory concentrations (MICs) around 625 ppm have been reported, with an observed enhancement of antibiotic efficacy (e.g., clindamycin against C. difficile). The oil also possesses strong antioxidant properties, scavenging free radicals and inhibiting lipid peroxidation, primarily attributed to its cinnamaldehyde and eugenol components, thereby supporting cellular protection against oxidative stress. Furthermore, systematic reviews indicate potential hypoglycemic effects, with some randomized controlled trials (RCTs) showing modest reductions in fasting blood glucose and HbA1c in type 2 diabetes patients, though effect sizes vary. Secondary effects include anti-inflammatory actions via inhibition of pro-inflammatory mediators, and potential neuroprotective and lipid-lowering effects, though these require further validation. Most clinical data on metabolic benefits focus on adults with type 2 diabetes, while antimicrobial and antioxidant benefits are largely demonstrated in vitro or in animal models. Meta-analyses report statistically significant but moderate glycemic improvements, and while antimicrobial effects are strong in vitro, clinical translation requires more evidence. Antimicrobial effects are rapid in vitro (minutes to hours), whereas metabolic effects require weeks to months of supplementation.
How it works
The primary bioactive compound, (E)-cinnamaldehyde, is central to the oil's mechanism of action. In microbial contexts, it interacts with and disrupts microbial cell membranes, leading to cell death. Its antioxidant activity is mediated by direct free radical scavenging and the inhibition of lipid peroxidation, protecting cells from oxidative damage. For metabolic effects, the oil's constituents are thought to enhance insulin signaling pathways and modulate glucose uptake, contributing to improved glycemic control. Additionally, the oil’s components can potentiate antibiotic activity by lowering bacterial resistance thresholds. Cinnamaldehyde is absorbed via the gastrointestinal tract, with its bioavailability influenced by formulation and co-ingestion with fats.
Side effects
Cinnamomum zeylanicum bark oil is generally regarded as safe when consumed in typical dietary amounts. However, common side effects, though rare, may include mild gastrointestinal discomfort or allergic reactions, particularly in individuals sensitive to cinnamon or related compounds. Ingestion of high doses or concentrated essential oil may lead to more severe adverse effects such as mucosal irritation or hepatotoxicity, although clinical data on these specific risks are limited. A significant concern is its potential interaction with antidiabetic medications, which could lead to hypoglycemia if not carefully monitored. Therefore, individuals on such medications should use this supplement with caution and under medical supervision. Contraindications include a known allergy to cinnamon. Due to limited safety data, special populations such as pregnant women and children should exercise caution and consult a healthcare professional before use.
Dosage
Clinical trials investigating cinnamon for glycemic control have typically used doses ranging from 120 mg to 6 g of cinnamon powder daily. For the essential oil, specific dosage recommendations are less established and generally require careful standardization due to its concentrated nature. There is no established maximum safe dose for the essential oil, and toxicity data suggest caution with high concentrations. To improve absorption and minimize potential gastrointestinal side effects, it is generally recommended to take the oil with meals. Formulations vary, including capsules, tinctures, or topical applications, and bioavailability may be enhanced when combined with lipid-based carriers. While cofactors such as other antioxidants may synergize with cinnamon oil’s effects, they are not strictly required for its efficacy.
FAQs
Is Cinnamomum zeylanicum bark oil safe for diabetes?
Evidence suggests modest glycemic benefits, but it should not replace standard medical therapy for diabetes and requires medical supervision due to potential interactions with antidiabetic medications.
Can it be used as an antimicrobial?
It shows strong in vitro antimicrobial effects against various pathogens, but it is not a substitute for prescription antibiotics. Its potential as an adjunct therapy is under investigation.
How quickly do effects appear?
Antimicrobial effects are rapid in vitro, often observed within minutes to hours. However, metabolic effects, such as improvements in blood glucose, typically require weeks to months of consistent supplementation.
Are there risks of overdose?
Yes, high doses of the essential oil may be toxic and can cause mucosal irritation or hepatotoxicity. It is crucial to use standardized extracts and avoid excessive intake to prevent adverse effects.
Research Sources
- https://pmc.ncbi.nlm.nih.gov/articles/PMC3854496/ – This in vitro study demonstrated the bactericidal activity of C. zeylanicum bark oil against E. coli, C. difficile, and fungi at MIC ~625 ppm. It also showed synergy with clindamycin against C. difficile, indicating its potential as an antimicrobial agent or an adjunct to antibiotics.
- https://pmc.ncbi.nlm.nih.gov/articles/PMC7210559/ – This study used GC-MS analysis to identify (E)-cinnamaldehyde as the major component (71.5%) of C. zeylanicum bark oil. It also demonstrated strong antioxidant activity via free radical scavenging assays, supporting the oil's role in cellular protection.
- https://onlinelibrary.wiley.com/doi/abs/10.1111/j.1464-5491.2012.03718.x – This systematic review and meta-analysis of RCTs found that C. zeylanicum powder modestly reduces fasting blood glucose and HbA1c in type 2 diabetes patients over 4-16 weeks. The effects were statistically significant but clinically moderate, with acceptable safety.